In order to elucidate the function of FABP3 and FABP4 protein expression during NSCLC progression, we correlated FABP3 and FABP4 protein expression with clinicopathological characteristics in NSCLC patients, including gender, age, histological type, TNM staging, smoking history, and differentiation. Here, FABP3 is linked to non-small cell lung carcinoma.